Author Archives: Mark McCarty

Life science confidential? Not lately

Share

The difference between good news and bad news

Share

5 for Five: Device coverage from the pages of MDD

Share

The problem in Washington: Is it really Capitol Hill?

The latest news about the Internal Revenue Service does nothing to comfort those who have to routinely interact with the agency, but it does seem to tie in with other behaviors by the Obama administration, regardless of whether anyone at…

Share

Three from MDD; Star Trek, big business, and human foibles

Share

The Week (so far) in med tech

April is not yet complete, but two items of interest already bear noting. One of these is perhaps the most important patent case to be heard by the Supreme Court in a long time, at least where life sciences are…

Share

Three for all: What’s new in 2013

Share

Heresy or common sense? Patients, statistics and medical devices

There’s no shortage of important developments in the world of medical devices, but today, let’s discuss this matter of dogmatic adherence to biostatistics. We’ve all heard about the FDA advisory committee that recently recommended the agency approve a neurostimulation device…

Share

Med-tech tax repeal: Is tax reform a viable vehicle?

Share

Congress and the doc fix: Is 2013 the year?

A clumsy attempt to address the Medicare Part B physician fee problem has nagged at Washington for a decade, but it appears Congress is ready to put a doc fix in play. Whether it’ll happen depends on politics and, as…

Share

Marketo